Nonetheless, ChIP-seq analysis identified TCF7L2 peaks in excitability/synaptic genes, the expression of which is enriched specifically in PV, PF or AD, implicating TCF7L2 in the direct control of subregional as well as pan-regional terminal selection in the thalamus. Here, TCF7L2 is linked to Alzheimer disease.